Renal Physiology — MCQs

Renal Physiology Indian Medical PG Practice Questions and MCQs

Question 121: In a patient with severe central diabetes insipidus caused by a lack of antidiuretic hormone secretion, which part of the nephron would have the lowest tubular fluid osmolarity?

A. Proximal convoluted tubule
B. Loop of Henle (descending limb)
C. Loop of Henle (ascending limb)
D. Collecting duct (Correct Answer)

Explanation: ### Explanation In **Central Diabetes Insipidus (DI)**, there is a deficiency of Antidiuretic Hormone (ADH). To understand where osmolarity is lowest, we must track the fluid's journey through the nephron under these conditions: 1. **The Mechanism (Why D is correct):** Normally, ADH acts on the V2 receptors of the **collecting ducts** to insert aquaporin-2 channels, allowing water reabsorption. In DI, the collecting duct remains **impermeable to water**. However, the reabsorption of solutes (like Na+ and Cl-) continues in the thick ascending limb and distal segments. Without ADH, water cannot follow these solutes out of the tubule. Consequently, the tubular fluid becomes progressively more dilute as it moves toward the end of the nephron, reaching its **lowest osmolarity (as low as 50–70 mOsm/L)** in the collecting duct before being excreted as dilute urine. 2. **Why other options are incorrect:** * **A. Proximal Convoluted Tubule:** Reabsorption here is **isosmotic**. The fluid remains at ~300 mOsm/L because water and solutes are reabsorbed in equal proportions. * **B. Loop of Henle (Descending):** This limb is permeable to water but not solutes. As it descends into the salty medulla, water leaves the tubule, making the fluid **hypertonic** (~1200 mOsm/L at the tip). * **C. Loop of Henle (Ascending):** This is the "diluting segment." Solutes are pumped out, but water cannot follow. While the osmolarity drops significantly here (to ~100 mOsm/L), it reaches its **absolute minimum** only in the collecting duct in the absence of ADH. ### NEET-PG High-Yield Pearls * **Site of maximum dilution:** In a healthy person with high water intake OR a DI patient, the **collecting duct** has the lowest osmolarity. * **Site of maximum concentration:** The **tip of the Loop of Henle** (medullary tip) and the **medullary collecting duct** (only in the presence of ADH). * **Free Water Clearance:** DI is characterized by positive free water clearance ($C_{H2O}$), leading to polyuria and hypernatremia.

Question 122: What is the tonicity of the fluid in the distal convoluted tubule (DCT)?

A. Hypotonic (Correct Answer)
B. Hypertonic
C. Isotonic
D. None of the above

Explanation: **Explanation:** The tonicity of the tubular fluid changes significantly as it passes through different segments of the nephron. The fluid entering the **Distal Convoluted Tubule (DCT)** is characteristically **hypotonic** (approximately 100 mOsm/L) compared to plasma (290 mOsm/L). **Why Option A is Correct:** This occurs because of the preceding action in the **Thick Ascending Limb (TAL)** of the Loop of Henle. The TAL is known as the **"diluting segment"** of the nephron. It actively reabsorbs solutes (via the $Na^+-K^+-2Cl^-$ symporter) but is strictly impermeable to water. As salt leaves the tubule without water following it, the luminal fluid becomes increasingly dilute. By the time it reaches the early DCT, the fluid is significantly more dilute than the surrounding interstitium and plasma. **Why Other Options are Incorrect:** * **Option B (Hypertonic):** Fluid is hypertonic only at the tip of the Loop of Henle (up to 1200 mOsm/L) due to the countercurrent multiplier system. * **Option C (Isotonic):** Fluid is isotonic (300 mOsm/L) in the **Proximal Convoluted Tubule (PCT)**, where water and solutes are reabsorbed in equal proportions (obligatory water reabsorption). **High-Yield Clinical Pearls for NEET-PG:** * **Early DCT:** Continues the dilution process via the **$Na^+-Cl^-$ cotransporter** (the target of **Thiazide diuretics**). It remains impermeable to water. * **Late DCT & Collecting Duct:** Tonicity here is **variable** and depends entirely on **Antidiuretic Hormone (ADH)**. In the presence of ADH, water is reabsorbed, making urine hypertonic; in its absence, urine remains hypotonic. * **Macula Densa:** Located at the junction of the TAL and DCT, it senses $Cl^-$ levels to regulate the Glomerular Filtration Rate (Tubuloglomerular feedback).

Question 123: Which of the following is the hallmark of chronic renal failure?

A. Metabolic acidosis (Correct Answer)
B. Hypercalcemia
C. Hypokalemia
D. Increased proneness to hypoxia

Explanation: **Explanation:** **Metabolic Acidosis (Correct Answer):** In Chronic Kidney Disease (CKD), metabolic acidosis is considered a hallmark feature due to the progressive loss of functioning nephrons. The kidneys fail to maintain acid-base balance through two primary mechanisms: 1. **Reduced Ammonia Synthesis:** There is a decreased ability of the proximal tubule to produce ammonia ($NH_3$), which is essential for buffering and excreting hydrogen ions ($H^+$). 2. **Reduced Titratable Acid Excretion:** Impaired phosphate filtration limits the excretion of $H^+$ as titratable acidity. This typically manifests as a **High Anion Gap Metabolic Acidosis (HAGMA)** in advanced stages as organic anions (sulfates, phosphates, urates) accumulate. **Why other options are incorrect:** * **Hypercalcemia:** CKD characteristically causes **Hypocalcemia**. This occurs due to the failure of 1-alpha-hydroxylase (leading to Vitamin D deficiency) and phosphate retention, which binds ionized calcium. * **Hypokalemia:** CKD typically leads to **Hyperkalemia** because of reduced distal tubular secretion of potassium, especially when the GFR falls below 15-20 mL/min. * **Increased proneness to hypoxia:** While CKD causes anemia (due to decreased Erythropoietin), "hypoxia" is not a diagnostic hallmark of renal failure itself, whereas the biochemical derangement of acidosis is. **High-Yield Clinical Pearls for NEET-PG:** * **Anemia in CKD:** Usually Normocytic Normochromic due to EPO deficiency. * **Renal Osteodystrophy:** The triad of secondary hyperparathyroidism, hypocalcemia, and hyperphosphatemia. * **First sign of CKD:** Often microalbuminuria (especially in diabetic nephropathy). * **Most common cause of death in CKD:** Cardiovascular disease, not uremia.

Question 124: Which substance is freely filtered by the kidney?

A. Creatinine
B. Inulin (Correct Answer)
C. PAHA
D. Glucose

Explanation: ### Explanation **1. Why Inulin is the Correct Answer:** Inulin is a fructose polymer that serves as the "gold standard" for measuring the Glomerular Filtration Rate (GFR). For a substance to be **freely filtered**, it must pass through the glomerular filtration barrier without restriction. Inulin meets all the criteria: * **Physicochemical properties:** It is small (MW ~5000 Da) and neutral, allowing it to bypass the size and charge barriers of the slit diaphragm. * **Renal handling:** Once filtered, it is **neither reabsorbed nor secreted** by the renal tubules. Therefore, the amount of inulin filtered is exactly equal to the amount excreted in the urine ($GFR \times P_{inulin} = U_{inulin} \times V$). **2. Analysis of Incorrect Options:** * **Creatinine (A):** While freely filtered, a small amount (approx. 10-20%) is **secreted** by the proximal tubules. This leads to a slight overestimation of GFR compared to inulin. * **PAH (Para-aminohippuric acid) (C):** PAH is freely filtered but is also **extensively secreted** by the organic anion transporters in the proximal tubule. Because it is almost completely cleared from the blood in one pass, it is used to measure **Effective Renal Plasma Flow (ERPF)**, not GFR. * **Glucose (D):** Glucose is freely filtered; however, in a healthy individual, it is **completely reabsorbed** in the proximal convoluted tubule (via SGLT2/1). Thus, its net clearance is zero. **3. High-Yield Clinical Pearls for NEET-PG:** * **Criteria for GFR Marker:** Must be freely filtered, not reabsorbed, not secreted, non-toxic, and not metabolized by the kidney. * **Clearance Ratios:** * $C_x / C_{inulin} < 1$: Substance is reabsorbed (e.g., Glucose, Urea). * $C_x / C_{inulin} > 1$: Substance is secreted (e.g., Creatinine, PAH). * **Filtration Fraction (FF):** $GFR / RPF$ (Normal $\approx 20\%$). Inulin clearance represents the numerator (GFR).

Question 125: Angiotensin-II mainly acts by which mechanism on the glomerulus?

A. Afferent arteriole dilatation
B. Efferent arteriole dilatation
C. Efferent arteriole constriction (Correct Answer)
D. Afferent arteriole constriction

Explanation: **Explanation:** **Mechanism of Action:** Angiotensin-II (AT-II) is a potent vasoconstrictor that plays a crucial role in maintaining the **Glomerular Filtration Rate (GFR)**, especially during states of low renal perfusion (e.g., hypotension or dehydration). While AT-II can constrict both arterioles, the **efferent arteriole** is significantly more sensitive to its effects. By selectively constricting the efferent arteriole, AT-II increases the "outflow resistance" from the glomerulus. This builds up hydrostatic pressure within the glomerular capillaries, thereby maintaining or increasing GFR even when renal blood flow is reduced. **Analysis of Options:** * **Option C (Correct):** Efferent arteriole constriction increases glomerular capillary hydrostatic pressure, which is the primary mechanism to preserve GFR. * **Option B (Incorrect):** Efferent dilatation would decrease glomerular pressure and drop the GFR. * **Option D (Incorrect):** While high concentrations of AT-II can cause some afferent constriction, its *predominant* and most physiologically significant effect at normal/moderate levels is on the efferent arteriole. * **Option A (Incorrect):** AT-II is a vasoconstrictor, not a vasodilator. Afferent dilatation is typically mediated by Prostaglandins (PGE2, PGI2) or ANP. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitors/ARBs:** These drugs block AT-II, leading to **efferent vasodilation**. This reduces intraglomerular pressure, which is "renoprotective" in diabetic nephropathy but can cause an acute drop in GFR in patients with bilateral renal artery stenosis. * **Prostaglandins vs. AT-II:** Remember the mnemonic: **A**fferent is affected by **P**rostaglandins (Dilate); **E**fferent is affected by **A**ngiotensin-II (Constrict). * **Filtration Fraction (FF):** Since AT-II decreases Renal Plasma Flow (RPF) but maintains GFR, it typically causes an **increase in the Filtration Fraction** (FF = GFR/RPF).

Question 126: Which set of arterial blood gas values describes a heavy smoker with COPD who is becoming increasingly somnolent?

A. pH: 7.65; HCO3-: 48 mEq/L; PCO2: 45 mmHg
B. pH: 7.5; HCO3-: 12 mEq/L; PCO2: 20 mmHg
C. pH: 7.4; HCO3-: 18 mEq/L; PCO2: 40 mmHg
D. pH: 7.2; HCO3-: 30 mEq/L; PCO2: 60 mmHg (Correct Answer)

Explanation: ### Explanation **1. Analysis of the Correct Answer (Option D)** The clinical scenario describes a patient with **COPD** (Chronic Obstructive Pulmonary Disease) who is becoming **somnolent**. This indicates **CO2 narcosis** due to severe hypoventilation. * **Respiratory Acidosis:** In COPD, impaired gas exchange leads to the retention of CO2 (Hypercapnia). A $PCO_2$ of 60 mmHg (>40 mmHg) confirms respiratory acidosis. * **Acidemia:** The pH of 7.2 (<7.35) confirms an uncompensated or partially compensated acidotic state. * **Renal Compensation:** In chronic respiratory acidosis, the kidneys retain $HCO_3^-$ to buffer the acidity. A $HCO_3^-$ of 30 mEq/L (Normal: 24 mEq/L) indicates partial metabolic compensation. **2. Analysis of Incorrect Options** * **Option A (pH 7.65, $HCO_3^-$ 48, $PCO_2$ 45):** This represents **Metabolic Alkalosis** (high pH and high $HCO_3^-$). This is not seen in COPD-induced respiratory failure. * **Option B (pH 7.5, $HCO_3^-$ 12, $PCO_2$ 20):** This represents **Respiratory Alkalosis** (high pH, low $PCO_2$) with renal compensation. This occurs in hyperventilation (e.g., anxiety or high altitude), not COPD. * **Option C (pH 7.4, $HCO_3^-$ 18, $PCO_2$ 40):** These values are near normal or represent a fully compensated mixed disorder, which does not fit the clinical picture of an acutely somnolent COPD patient. **3. High-Yield Clinical Pearls for NEET-PG** * **CO2 Narcosis:** High levels of $PaCO_2$ (typically >60-70 mmHg) act as a central nervous system depressant, leading to somnolence and coma. * **Compensation Rule:** In **Chronic** Respiratory Acidosis, for every 10 mmHg rise in $PCO_2$, $HCO_3^-$ increases by **3.5 to 4 mEq/L**. * **Winter’s Formula:** Used to calculate expected $PCO_2$ in metabolic acidosis: $PCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2$.

Question 127: Concentrating ability of the kidney is impaired if:

A. There is damage to the glomerulus
B. There is excess secretion of ADH
C. There is vigorous activity of the Na+-K+-pump
D. Blood flow through the vasa recta is increased substantially (Correct Answer)

Explanation: **Explanation:** The kidney’s ability to concentrate urine depends on the **medullary osmotic gradient** (high interstitial osmolarity). This gradient is maintained by the **Vasa Recta** through a process called **Countercurrent Exchange**. **Why Option D is Correct:** The vasa recta are specialized capillaries that provide nutrients to the medulla without "washing out" the solutes (NaCl and Urea) necessary for the osmotic gradient. They have a slow blood flow to allow for efficient exchange. If **blood flow increases substantially**, the rapid transit of blood removes solutes from the medullary interstitium faster than they can be replaced. This is known as **"Medullary Washout."** Without a high interstitial osmolarity, water cannot be reabsorbed from the collecting ducts, leading to impaired concentrating ability. **Why Other Options are Incorrect:** * **A. Damage to the glomerulus:** This primarily affects the **filtration rate (GFR)** and may lead to proteinuria or azotemia, but it does not directly abolish the medullary gradient required for concentration. * **B. Excess secretion of ADH:** ADH (Vasopressin) *increases* water reabsorption by inserting aquaporins in the collecting ducts. This **enhances** the kidney's ability to concentrate urine (seen in SIADH). * **C. Vigorous activity of Na+-K+-pump:** The Na+-K+-2Cl- symporter (and associated pumps) in the Thick Ascending Limb is the "engine" of the **Countercurrent Multiplier**. Increased activity would **strengthen** the medullary gradient, improving concentrating ability. **High-Yield NEET-PG Pearls:** * **Countercurrent Multiplier:** Loop of Henle (Creates the gradient). * **Countercurrent Exchanger:** Vasa Recta (Maintains the gradient). * **Urea Recycling:** Contributes nearly 50% of the medullary hyperosmolarity; stimulated by ADH. * **Obligatory Water Loss:** The minimum urine volume required to excrete metabolic waste (~0.5 L/day).

Question 128: Where is renin synthesized?

A. Granular cells (Correct Answer)
B. Intercalated cells
C. Interstitial cells
D. Macula densa cells

Explanation: **Explanation:** Renin is a proteolytic enzyme essential for blood pressure regulation via the Renin-Angiotensin-Aldosterone System (RAAS). **1. Why Granular Cells are Correct:** Renin is synthesized, stored, and secreted by the **Granular cells** (also known as Juxtaglomerular or JG cells). These are specialized **modified smooth muscle cells** located primarily in the tunica media of the **afferent arteriole** (and to a lesser extent, the efferent arteriole). They act as intrarenal baroreceptors, sensing changes in renal perfusion pressure and releasing renin in response to hypotension or sympathetic stimulation. **2. Why the other options are incorrect:** * **Intercalated cells:** Found in the collecting ducts, these cells are responsible for acid-base balance (Type A secretes $H^+$; Type B secretes $HCO_3^-$), not hormone synthesis. * **Interstitial cells:** In the kidney, these cells (specifically peritubular fibroblasts) are the primary site for **Erythropoietin (EPO)** production. * **Macula densa cells:** These are specialized columnar epithelial cells in the Thick Ascending Limb (TAL). They act as **chemoreceptors** that sense sodium chloride ($NaCl$) delivery. While they trigger renin release from granular cells via paracrine signaling (Prostaglandins), they do not synthesize renin themselves. **Clinical Pearls for NEET-PG:** * **Juxtaglomerular Apparatus (JGA):** Comprises Granular cells, Macula densa, and Lacis cells (Extraglomerular mesangial cells). * **Stimuli for Renin Release:** 1. Decreased renal perfusion pressure (Baroreceptor mechanism), 2. Decreased NaCl delivery to macula densa, 3. Increased Sympathetic activity ($\beta_1$ receptors). * **Rate-limiting step:** Renin release is the rate-limiting step of the RAAS cascade.

Question 129: The tubuloglomerular feedback is mediated by:

A. Sensing of Na+ concentration in the macula densa
B. Sensing of Cl- concentration in macula densa
C. Sensing NaCl concentration in the macula densa (Correct Answer)
D. Opening up of voltage-gated Na+ channels in afferent arteriole

Explanation: **Explanation:** **Tubuloglomerular Feedback (TGF)** is an intrinsic autoregulatory mechanism of the kidney where the **Macula Densa** (specialized cells in the Thick Ascending Limb) senses changes in the tubular fluid to regulate the Glomerular Filtration Rate (GFR). **Why Option C is Correct:** The primary sensor for TGF is the **NKCC2 transporter** (Na+-K+-2Cl- cotransporter) located on the apical membrane of macula densa cells. While both Na+ and Cl- are transported, research indicates that the macula densa specifically monitors the **total NaCl concentration**. When GFR increases, more NaCl reaches the macula densa. This leads to increased NaCl uptake, triggering the release of **Adenosine**, which causes vasoconstriction of the **Afferent Arteriole**, thereby normalizing GFR. **Analysis of Incorrect Options:** * **Options A & B:** While Na+ and Cl- are both sensed, they are sensed together via the NKCC2 transporter. Isolating one over the other is physiologically inaccurate as the transporter requires the presence of both ions to function. * **Option D:** TGF involves the opening of **stretch-activated non-specific cation channels** and calcium-activated channels, but the primary effector mechanism in the afferent arteriole is mediated by **Adenosine (A1 receptors)** and an increase in intracellular Calcium, not voltage-gated Na+ channels. **High-Yield NEET-PG Pearls:** * **The "Sensor":** Macula Densa. * **The "Effector":** Afferent Arteriole (Vasoconstriction). * **The "Mediator":** Adenosine (ATP is the precursor). * **Clinical Correlation:** Loop diuretics (e.g., Furosemide) inhibit the NKCC2 transporter, effectively "blunting" the TGF mechanism. * **Opposite Effect:** A decrease in NaCl at the macula densa stimulates the **Juxtaglomerular cells** to release **Renin**, activating the RAAS pathway.

Question 130: Decreased erythropoietin levels are seen in which of the following conditions?

A. End stage renal disease (Correct Answer)
B. Heart failure
C. Polycytic kidney disease
D. Advanced liver failure

Explanation: ### Explanation **Correct Option: A. End stage renal disease (ESRD)** Erythropoietin (EPO) is a glycoprotein hormone primarily produced by the **interstitial fibroblasts in the peritubular capillary bed** of the renal cortex (approx. 85-90%). In ESRD, the progressive destruction of functional renal parenchyma and subsequent fibrosis lead to a profound loss of these EPO-producing cells. This deficiency is the primary cause of normocytic, normochromic anemia in chronic kidney disease. **Analysis of Incorrect Options:** * **B. Heart Failure:** Chronic heart failure often leads to a state of relative tissue hypoxia and decreased renal perfusion. This stimulates the Hypoxia-Inducible Factor (HIF) pathway, typically resulting in **increased** or compensatory EPO levels. * **C. Polycystic Kidney Disease (PKD):** Unlike other forms of renal failure, PKD is often associated with **normal or elevated** EPO levels. The cysts can cause local tissue hypoxia or the cyst-lining cells themselves may inappropriately secrete EPO, sometimes leading to polycythemia despite declining renal function. * **D. Advanced Liver Failure:** While the liver produces about 10-15% of adult EPO, liver failure does not typically cause a significant decrease in systemic EPO levels because the kidneys (the primary source) remain intact. Anemia in liver disease is usually multifactorial (e.g., hypersplenism, malnutrition). **High-Yield Facts for NEET-PG:** * **Stimulus for EPO:** The primary stimulus is **hypoxia** (detected by prolyl hydroxylase sensors), not the number of red blood cells. * **Site of Action:** EPO acts on the **CFU-E (Colony Forming Unit-Erythroid)** receptors in the bone marrow to prevent apoptosis of red cell precursors. * **Clinical Pearl:** Recombinant human erythropoietin (Epoetin alfa) is a mainstay treatment for anemia in ESRD, but it can cause **hypertension** as a common side effect.

Practice by Chapter

Renal Blood Flow and Glomerular Filtration

Practice Questions

Tubular Reabsorption and Secretion

Practice Questions

Concentration and Dilution of Urine

Practice Questions

Acid-Base Regulation by the Kidneys

Practice Questions

Sodium and Water Balance

Practice Questions

Potassium Regulation

Practice Questions

Calcium and Phosphate Handling

Practice Questions

Micturition Physiology

Practice Questions

Renal Function Tests

Practice Questions

Integrative Responses to Fluid Challenges

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free